Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

CAS 32018-96-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 32018-96-5
Also known as: 32018-96-5, 1-benzyl-4-methyl-piperidin-3-one, 4-methyl-1-(phenylmethyl)-3-piperidinone, 3-piperidinone, 4-methyl-1-(phenylmethyl)-, Mfcd16619159, Schembl1105751
Molecular Formula
C13H17NO
Molecular Weight
203.28  g/mol
InChI Key
BSBVJNUGGBQEPO-UHFFFAOYSA-N

1 2D Structure

CAS 32018-96-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-benzyl-4-methylpiperidin-3-one
2.1.2 InChI
InChI=1S/C13H17NO/c1-11-7-8-14(10-13(11)15)9-12-5-3-2-4-6-12/h2-6,11H,7-10H2,1H3
2.1.3 InChI Key
BSBVJNUGGBQEPO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1CCN(CC1=O)CC2=CC=CC=C2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 32018-96-5

2. 1-benzyl-4-methyl-piperidin-3-one

3. 4-methyl-1-(phenylmethyl)-3-piperidinone

4. 3-piperidinone, 4-methyl-1-(phenylmethyl)-

5. Mfcd16619159

6. Schembl1105751

7. Amy4191

8. Dtxsid00477278

9. 1-benzyl-4-methyl-3-piperidinone

10. 1-benzyl 4-methyl-piperidin-3-one

11. Akos007930647

12. Sb36567

13. Ac-27439

14. As-61188

15. Db-068566

16. A5763

17. Cs-0006817

18. Ft-0720137

19. En300-78889

20. 018m965

21. 1-benzyl-4-methylpiperidin-3-one 32018-96-5

22. 2-([(4-chlorophenyl)sulfonyl]amino)aceticacid

23. 1-benzyl-4-methyl-piperidin-3-one;1-benzyl-4-methylpiperidin-3-one

2.3 Create Date
2007-02-07
3 Chemical and Physical Properties
Molecular Weight 203.28 g/mol
Molecular Formula C13H17NO
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass203.131014166 g/mol
Monoisotopic Mass203.131014166 g/mol
Topological Polar Surface Area20.3 Ų
Heavy Atom Count15
Formal Charge0
Complexity221
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
1062580-52-2
Tofacitinib Citrate
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs...
Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-growth therapeutic areas, with an emphasis on affordability, quality and timely delivery. It also provides end-to-end CDMO services. Headquartered in Hyderabad, Tagoor Labs is a fast-growing Indian pharma company that serves both branded and generic companies worldwide. The company’s organizational function includes R&D, supply chain, manufacturing, quality testing, quality assurance, regulatory affairs, marketing & sales, and packaging & warehousing departments.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY